Search

everythinglearnresearchcommunity

for

Search:↓

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

The technique effectively promotes hair growth in young men with androgenetic alopecia.

PRP is an effective and safe treatment for hair loss in women.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Topical tofacitinib is effective and safe for treating alopecia areata.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.